Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that Wetteny Joseph, Senior
Vice President & Chief Financial Officer, and Thomas Castellano, Vice
President Finance, Investor Relations and Treasurer will present at the
following conferences in the coming weeks.
2018 RBC Capital Markets Global Healthcare Conference
Location: New
York, NY
Date: Thursday, February 22, 2018
Presentation: 11:00
a.m. ET
Raymond James 39th Annual Institutional Investors Conference
Location:
Orlando, FL
Date: Monday, March 5, 2018
Presentation: 11:00
a.m. ET
A live webcast of the presentations will be accessible through the
Company’s website at http://investor.catalent.com
and will be available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and consumer
health products. With over 80 years serving the industry, Catalent has
proven expertise in bringing more customer products to market faster,
enhancing product performance and ensuring reliable clinical and
commercial product supply. Catalent employs over 10,000 people,
including over 1,400 scientists, at more than 30 facilities across 5
continents and in fiscal 2017 generated more than $2 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
Investor Contact:
Catalent, Inc.
Thomas Castellano, 732-537-6325
investors@catalent.com